Paul W. M. Fedak

Reply: Final Common Pathway of Aortic Dilation?: Heterogeneity of Aortic Wall Property Causes the Aneurysmal Change.

Bicuspid aortic valve aortopathy: mechanistic and clinical insights from recent studies.

Heparin Augmentation Enhances Bioactive Properties of Acellular Extracellular Matrix Scaffold.

Adhesive-Enhanced Sternal Closure: Feasibility and Safety of Late Sternal Reentry.

The Cost of Frailty in Cardiac Surgery.

Evolution of Precision Medicine and Surgical Strategies for Bicuspid Aortic Valve-Associated Aortopathy.

Bicuspid aortic valve-associated aortopathy: update on biomarkers.

Mind the Gap: Current Challenges and Future State of Heart Failure Care.

Perioperative evaluation of regional aortic wall shear stress patterns in patients undergoing aortic valve and/or proximal thoracic aortic replacement.

Seeing a tree through the forest: Precision medicine tools can enhance donor allocation in heart transplantation.

Bridging to heart transplant with extracorporeal membrane oxygenation: Good or VAD?

Aortic diameter: The beginning of the end of an era.

Aortic Valve Replacement in an Era of Rapid Innovation: Better the Devil You Know.

Using Acellular Bioactive Extracellular Matrix Scaffolds to Enhance Endogenous Cardiac Repair.

Human pericardial proteoglycan 4 (lubricin): Implications for postcardiotomy intrathoracic adhesion formation.

The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Executive summary.

The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only version.

Aortic valve-mediated wall shear stress is heterogeneous and predicts regional aortic elastic fiber thinning in bicuspid aortic valve-associated aortopathy.

Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure.

Bioactive Extracellular Matrix Scaffold Promotes Adaptive Cardiac Remodeling and Repair.

Modify, simplify, apply: Do we need preclinical models for surgical innovation?

Make sternotomy great again.

Commentary: Structural valve degeneration in the era of precision medicine.

Coronary Bypass Surgery for Diabetes and Multivessel Disease: Forget the SYNTAX.

Induction of human aortic myofibroblast-mediated extracellular matrix dysregulation: A potential mechanism of fluoroquinolone-associated aortopathy.

Validating innovations to improve recovery after heart surgery.

Targeting selected extracellular matrix components to attenuate cardiac fibrosis.

Precision and targeted therapy in cardiac surgery.

Utilizing wall shear stress as a clinical biomarker for bicuspid valve-associated aortopathy.

Commentary: Using ex vivo modeling to validate technical innovations in cardiac surgery.

Minimally invasive cardiac surgery and the importance of qualitative patient-centered metrics to guide innovations.

Evolving Surgical Approaches to Bicuspid Aortic Valve Associated Aortopathy.

Minimally invasive cardiac surgery presents challenges for design of randomized clinical trials.

Acellular Extracellular Matrix Bioscaffolds for Cardiac Repair and Regeneration.

Gata6 Pericardial Cavity Macrophages Relocate to the Injured Heart and Prevent Cardiac Fibrosis.

On the 'cusp' of clinical feasibility: aortic wall shear stress derived non-invasively with 4D flow MRI.

Application of Bioengineered Materials in the Surgical Management of Heart Failure.

Commentary: Cause or consequence? The influence of mitral regurgitation on post-myocardial infarction structural remodeling is better defined using a new rodent model.

SKA-31, an activator of Ca-activated K channels, improves cardiovascular function in aging.

Commentary: The promise of precision cardiovascular surgery.

Direct Effects of Empagliflozin on Extracellular Matrix Remodelling in Human Cardiac Myofibroblasts: Novel Translational Clues to Explain EMPA-REG OUTCOME Results.

Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials.

Applications of a Specialty Bicuspid Aortic Valve Program: Clinical Continuity and Translational Collaboration.

Fluoroquinolone-Associated Type A Aortic Dissection in Alpha-1 Anti-Trypsin Deficiency.

Acellular bioscaffolds redirect cardiac fibroblasts and promote functional tissue repair in rodents and humans with myocardial injury.

The science of BAV aortopathy.

Surgical management of the aorta in BAV patients.

Commentary: The return on investment for cardiothoracic surgeon-scientists.

Commentary: The mutation matters: Improving precision for surgical management of hereditary aortic syndromes.

Commentary: Transplanting the powerhouse of the cell to enhance cardiopulmonary repair.

Commentary: Fluoroquinolone antibiotics are antiaortic.

Commentary: A picture is worth a thousand words: Improving surgical approaches using advanced multimodal cardiac imaging.

Commentary: Past is Prologue - Leveraging Big Data to Optimize Future Operative Risk Prediction.

Mechanical and Structural Remodeling of Cardiac Muscle after Aerobic and Resistance Exercise Training in Rats.

Commentary: How to save and improve the lives of families with heritable aortic diseases.

Commentary: The 4AT score-Reducing confusion about delirium diagnosis after cardiac surgery.

Summary: international consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes.

International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes.

International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes.

Summary: International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes.

Summary: International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional, and research purposes.

International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes.

Aorta-specific DNA methylation patterns in cell-free DNA from patients with bicuspid aortic valve-associated aortopathy.

Prevention of Post-Operative Adhesions: A Comprehensive Review of Present and Emerging Strategies.

Post-Operative Adhesions: A Comprehensive Review of Mechanisms.

Potential role of epicardial adipose tissue in coronary artery endothelial cell dysfunction in type 2 diabetes.